FibroScan-Reproducibility and Repeatability Study
- Conditions
- Non-Alcoholic Fatty Liver DiseaseLiver Disease; Alcohol-Related
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Echosens
- Target Recruit Count
- 108
- Registration Number
- NCT06877026
- Locations
- 🇬🇧
King's College Hospital NHS Foundation Trust, London, England, United Kingdom
Development of a New Method for Liver Stiffness Measurement Using FibroScan
- Conditions
- Liver Diseases
- Interventions
- Device: Research FibroScan (FS)
- First Posted Date
- 2024-07-25
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Echosens
- Target Recruit Count
- 114
- Registration Number
- NCT06519331
- Locations
- 🇫🇷
Hôpital Pitié-Salpêtrière, Paris, Ile De France, France
🇫🇷Groupe Hospitalier Nord Essonne - Site Paris- Saclay, Orsay, France
Validation of the New Vibration-guided FibroScan Examination
- Conditions
- Liver Diseases
- Interventions
- Device: Research FibroScan (FS)
- First Posted Date
- 2022-10-05
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Echosens
- Target Recruit Count
- 270
- Registration Number
- NCT05567328
- Locations
- 🇫🇷
Hôpital Beaujon, Clichy, France
🇫🇷Hospices Civils de Lyon - Lyon Sud, Lyon, France
🇫🇷CHU de Nancy, Nancy, France
Optimization of Spleen VCTE Examinations with FibroScan
- Conditions
- Spleen; Fibrosis
- Interventions
- Device: FibroScan examination (M)Device: FibroScan examination (XL)Device: FibroScan examination (S)Device: FibroScan examination (Standard M)
- First Posted Date
- 2021-11-16
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Echosens
- Target Recruit Count
- 433
- Registration Number
- NCT05122416
- Locations
- 🇳🇱
University Medical Center Rotterdam, Rotterdam, Netherlands
🇷🇴Regional Institute of Gastroenterology and Hepatology "Octavian Fodor" (IRGH), Cluj-Napoca, Romania
🇪🇸Hospital Puerta de Hierro Majadahonda, Madrid, Spain
Development of Predictive Indicators of Homogeneous Propagation of Ultrasound and Elastic Waves During VCTE Examination
- Conditions
- Liver Fibrosis
- Interventions
- Device: Research FibroScan
- First Posted Date
- 2021-02-10
- Last Posted Date
- 2021-10-13
- Lead Sponsor
- Echosens
- Target Recruit Count
- 200
- Registration Number
- NCT04747457
- Locations
- 🇫🇷
CHU d'Amiens, Amiens, France
🇫🇷CHU d'Angers, Angers, France
🇫🇷CHU de Lille, Lille, France
Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients
- Conditions
- Obesity, MorbidLiver Fibrosis
- First Posted Date
- 2019-03-12
- Last Posted Date
- 2022-08-08
- Lead Sponsor
- Echosens
- Target Recruit Count
- 180
- Registration Number
- NCT03872024
- Locations
- 🇫🇷
Hôpital la Pitié Salpêtrière, Paris, France
Validation of the Second Generation of the Controlled Attenuation Parameter (CAP) Using the MRI-PDFF as Reference
- Conditions
- Chronic Liver Disease
- Interventions
- Device: FibroScan 530 Compact
- First Posted Date
- 2018-10-15
- Last Posted Date
- 2022-08-08
- Lead Sponsor
- Echosens
- Target Recruit Count
- 207
- Registration Number
- NCT03704792
- Locations
- 🇫🇷
Centre Hospitalier Universitaire d'Angers, Angers, France
🇫🇷Hôpitaux Universitaires Paris Seine Saint-Denis - Service Hépatologie, Bondy, France
🇫🇷Centre Hospitalier Universitaire de Bordeaux - Hôpital Haut Lévêque, Bordeaux, France
Spleen Stiffness Measurement With FibroScan
- Conditions
- Cirrhosis
- Interventions
- Device: Fibroscan® examination
- First Posted Date
- 2014-07-02
- Last Posted Date
- 2018-10-10
- Lead Sponsor
- Echosens
- Target Recruit Count
- 403
- Registration Number
- NCT02180113
- Locations
- 🇫🇷
CHU, Service Hépato-gastroentérologie, Angers, France
🇫🇷Hôpital Jean Verdier, Service Hépato-gastroentérologie, Bondy, France
🇫🇷Hôpital Haut-Lévêque, Service Hépato-gastroentérologie et Oncologie digestive, Pessac, France
Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.
- Conditions
- Non-alcoholic Fatty Liver Disease
- Interventions
- Device: FibroScan® examination.
- First Posted Date
- 2013-11-15
- Last Posted Date
- 2017-07-27
- Lead Sponsor
- Echosens
- Target Recruit Count
- 450
- Registration Number
- NCT01985009
- Locations
- 🇬🇧
Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom
🇬🇧Addenbrooke's Hospital, Cambridge, United Kingdom
🇬🇧Royal Free Hospital, London, United Kingdom
Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients
- Conditions
- Liver FibrosisCirrhosis
- First Posted Date
- 2009-06-23
- Last Posted Date
- 2010-11-16
- Lead Sponsor
- Echosens
- Target Recruit Count
- 300
- Registration Number
- NCT00926224
- Locations
- 🇨🇦
Calgary University Hospital, Calgary, Alberta, Canada
🇨🇦London University Hospital, London, Ontario, Canada
🇨🇦Toronto Western General Hospital, Toronto, Ontario, Canada